Strs Ohio Grows Stake in HCA Healthcare, Inc. $HCA

Strs Ohio increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 14.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 90,280 shares of the company’s stock after buying an additional 11,242 shares during the quarter. Strs Ohio’s holdings in HCA Healthcare were worth $38,477,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also modified their holdings of the business. Brighton Jones LLC acquired a new stake in HCA Healthcare in the 4th quarter worth approximately $1,021,000. NewEdge Advisors LLC increased its position in shares of HCA Healthcare by 11.9% in the 1st quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after acquiring an additional 409 shares during the period. Sivia Capital Partners LLC lifted its position in HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after acquiring an additional 33 shares during the period. Farther Finance Advisors LLC increased its holdings in shares of HCA Healthcare by 22.6% in the second quarter. Farther Finance Advisors LLC now owns 1,399 shares of the company’s stock valued at $536,000 after purchasing an additional 258 shares during the period. Finally, Fifth Third Bancorp boosted its position in HCA Healthcare by 2.0% in the second quarter. Fifth Third Bancorp now owns 9,350 shares of the company’s stock valued at $3,582,000 after buying an additional 186 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the topic of several recent research reports. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of HCA Healthcare in a report on Monday, October 27th. Leerink Partners increased their price target on HCA Healthcare from $470.00 to $507.00 and gave the stock an “outperform” rating in a research report on Thursday, January 15th. Mizuho upped their target price on HCA Healthcare from $505.00 to $520.00 and gave the stock an “outperform” rating in a research note on Thursday, December 18th. The Goldman Sachs Group boosted their price target on HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a report on Monday, October 27th. Finally, Barclays lifted their target price on shares of HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $488.75.

HCA Healthcare Stock Up 0.9%

Shares of NYSE HCA opened at $470.52 on Friday. HCA Healthcare, Inc. has a 52-week low of $295.00 and a 52-week high of $520.00. The company’s 50-day simple moving average is $480.37 and its 200-day simple moving average is $433.53. The firm has a market cap of $107.37 billion, a price-to-earnings ratio of 18.19, a price-to-earnings-growth ratio of 1.28 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. During the same period last year, the company posted $4.90 EPS. HCA Healthcare’s quarterly revenue was up 9.6% compared to the same quarter last year. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.